The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

A drug already used in the treatment of severe asthma could help treat exacerbations in asthma and COPD, a UK trial has found ...

An injection of a drug already on the market, Benralizamab, promises to be the next revolution in the treatment of asthma ...

Apogee plans to take a combination approach to AD by targeting Types 1-3 inflammation potentially offering JAK-like inhibition without their ...

Positive interim Phase 1 data indicate APG808 was well-tolerated with half-life of approximately 55 days, supporting potential for 2- to 3- month ...

A look at some of the health news and happenings from over the weekend Labour makes pre-election promise to build Dunedin ...